好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Factors Predicting In-Hospital Mortality in Ischemic Stroke Patients in Bogotá, Colombia
Cerebrovascular Disease and Interventional Neurology
P10 - Poster Session 10 (5:00 PM-6:00 PM)
14-009

To determine the in-hospital predictors of mortality of ischemic stroke (IS) patients in a single institution in Bogota, Colombia.

Stroke is the second leading cause of death and the primary cause of disability worldwide. While risk factors for IS are well-documented in large cohorts from high-income countries, studies addressing predictive factors in middle and middle-upper income countries remain scarce.

Cross-sectional retrospective study including patients with acute IS admitted to the Neurohospitalist Department at a single institution in Bogotá, Colombia. Sociodemographic, clinical, and outcome variables were retrieved from electronic medical records from 2020 to 2022. Age- and sex-adjusted logistic regression analyses were performed using SPSS v25.

820 patients were included. Factors associated with higher in-hospital mortality from IS included a history of coronary artery disease (OR=2.57, CI95%:[1.63-4.03]), atrial fibrillation (OR=2.38, CI95%:[1.61-3.50]), type 2 diabetes (OR=1.79, CI95%:[1.18-2.71]), SARS-CoV-2 infection within the prior six months (OR=4.90, CI95%:[2.73-8.80]), moderate-severe stroke at admission (OR=5.97, CI95%:[3.03-11.74]), and large vessel occlusion (OR=2.34, CI95%:[1.45-3.75]). In-hospital complications such as hemorrhagic transformation (OR=2.44, CI95%:[1.30-4.56]), aspiration pneumonia (OR=8.99, CI95%:[4.92-16.44]) and tracheitis (OR=5.13, CI95%:[2.29-11.50]), along with procedures such as craniectomy (OR=4.59, CI95%:[1.36-15.42]), gastrostomy (OR=4.87 CI95%:[2.68-8.86]), and tracheostomy (OR=6.86 CI95%:[3.24-14.56]) were also associated with an increased mortality.

In this study, the factors associated with acute IS mortality included prior cardiovascular diseases, complications related to the condition, and required ancillary invasive procedures. Policymakers and stroke centers in middle-upper income countries must focus on addressing these factors to improve stroke mortality outcomes.

Authors/Disclosures
Stefanía Forero Caldas, MD
PRESENTER
Dr. Forero Caldas has nothing to disclose.
Annelise Pereira Mrs. Pereira has nothing to disclose.
Juan D. Martinez Lemus, MD (The University of Texas Health Science Center at Houston) Dr. Martinez Lemus has nothing to disclose.
Neiry Maria Zapa Pérez Ms. Zapa Pérez has nothing to disclose.
Mariana Medina, Sr., MD Dr. Medina has nothing to disclose.
Juana V. Navarro, MD Dr. Navarro has nothing to disclose.
Yula A. Ponguta Merchan Mrs. Ponguta has nothing to disclose.
Delia S. Giraldo Peñuela, MD Dr. Giraldo Peñuela has nothing to disclose.
Hernan Bayona, MD (Independent) Dr. Bayona has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Aventis. Dr. Bayona has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer-Ingelheim. Dr. Bayona has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer SA. Dr. Bayona has received publishing royalties from a publication relating to health care.
Claudio A. Monsalve, MD Mr. Monsalve has nothing to disclose.